Tag: Hepatitis C
-
ACG Experts Highlight Key Abstracts, Offer Real-World Insights in Pre-Recorded Virtual Press Briefings
American College of Gastroenterology / Posts / News / ACG Experts Highlight Key Abstracts, Offer Real-World Insights in Pre-Recorded Virtual Press BriefingsThis year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts…
-
Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT -450/R/Ombitasvir, Dasabuvir and Ribavirin
American College of Gastroenterology / Posts / Uncategorized / Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT -450/R/Ombitasvir, Dasabuvir and RibavirinOral 5: Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT-450/R/Ombitasvir, Dasabuvir and…
-
SVR12 of 99% Achieved With a Ribavirin-Free Regiment of ABT-450r Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients
American College of Gastroenterology / Posts / Uncategorized / SVR12 of 99% Achieved With a Ribavirin-Free Regiment of ABT-450r Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected PatientsOral 4: SVR12 (sustained virologic response 12 weeks post-treatment) of 99% Achieved With a Ribavirin-Free Regiment Author Insight from Andreas…
-
Health Related Quality of Life (HRQL) and Health Utilities (HU) of Patients With Chronic Hepatitis C (CH-C) Treated With an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV) and Sofosbuvir (SOF)
American College of Gastroenterology / Posts / Uncategorized / Health Related Quality of Life (HRQL) and Health Utilities (HU) of Patients With Chronic Hepatitis C (CH-C) Treated With an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV) and Sofosbuvir (SOF)Plenary Session 2: Liver Tuesday, October 21 8:30 am – 10:00 am MODERATORS: Kris V. Kowdley, MD, FACG Paul Y.…